Skip to content
Episode 152 - August 15, 2025  episode artwork

Aug 15, 2025 1 hr

Episode 152 - August 15, 2025

from Biotech Hangout Hosted by Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more

On this week’s episode, Josh Schimmer, Eric Schmidt, and Tess Cameron kick off with policy, discussing Vinay Prasad’s return to the FDA and the implications for the biotech industry. The conversation turns to NIH’s Jay Bhattacharya, who attributed the decline in public trust in mRNA vaccines to perception rather than safety or efficacy, citing this as the reason to curtail funding. In market trends, the co-hosts discuss investor blind spots, specifically near-term product launches. Next, the group examines whether rising drug prices are sustainable and the six-month IPO drought. They also debate how non-commercial companies approach earnings calls, pointing to Summit Therapeutics’ choice to skip its Q2 call and whether most development-stage biotechs should follow suit. ARS Pharmaceuticals’ earnings/epinephrine nasal spray launch and RTW Investments deal with Aquestive Therapeutics are also overviewed. The episode concludes with data news, covering Insmed’s lung disease approval and Sarepta’s safety update. *This episode aired on August 15, 2025.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Episode 152 - August 15, 2025

0:00 1:00:21

No transcript yet.

Requests help us decide what to transcribe next.

Talking Biotech with Dr. Kevin Folta Kevin Folta Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering.Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050.Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics. State of Digital Clinical Trials Podcast Veeva State of Digital Clinical Trials is a Veeva podcast hosted by Manny Vazquez, Director, Clinical Data Strategy. Manny will be speaking to a series of expert guests from across pharma, biotech, and CROs to discuss their experiences, challenges, and ideas for the future of digital clinical trials. Will new technology make clinical trials more patient- and site-centric? The Biotech Startups Podcast Excedr The Biotech Startups Podcast by Excedr features weekly conversations with founders, scientists, and investors driving biotech innovation. Host Jon Chee dives into the challenges of building biotech startups, from pre-seed to IPO. New episodes every Monday and Thursday. Healthcare NOW Radio Podcast Network - Discussions on healthcare including technology, innovation, policy, data security, telehealth and more. Visit HealthcareNOWRadio.com Healthcare NOW Radio and Podcast Network - Radio and Podcasts for the Healthcare Industry RADIO FOR THE HEALTHCARE INDUSTRYHealthcare NOW Radio and Podcast Network offers discussions on the latest developments and trends impacting the industry including: health tech, health IT, healthcare innovation, healthcare policy, healthcare data security, telehealth, interoperability, biotech, med tech, value-based care, pharma, healthcare compliance, and much more. Shows are hosted by industry thought leaders. Guests are a "who's who" across the healthcare spectrum. The listening audience is predominantly physician and hospital-based, and the healthcare industry at large.

Frequently asked questions

How long is this episode of Biotech Hangout?

This episode is 1 hour and 0 minutes long.

When was this Biotech Hangout episode published?

This episode was published on August 15, 2025.

Can I download this Biotech Hangout episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.